KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2018 - 2025)

Historic Interest Coverage Ratio for Vertex Pharmaceuticals (VRTX) over the last 10 years, with Q4 2025 value amounting to 365.42.

  • Vertex Pharmaceuticals' Interest Coverage Ratio fell 27.41% to 365.42 in Q4 2025 from the same period last year, while for Dec 2025 it was 313.78, marking a year-over-year increase of 422268.26%. This contributed to the annual value of 313.78 for FY2025, which is 422268.26% up from last year.
  • Vertex Pharmaceuticals' Interest Coverage Ratio amounted to 365.42 in Q4 2025, which was down 27.41% from 359.45 recorded in Q3 2025.
  • Vertex Pharmaceuticals' 5-year Interest Coverage Ratio high stood at 366.43 for Q4 2024, and its period low was 355.02 during Q2 2024.
  • Moreover, its 3-year median value for Interest Coverage Ratio was 148.84 (2024), whereas its average is 163.27.
  • Examining YoY changes over the last 5 years, Vertex Pharmaceuticals' Interest Coverage Ratio showed a top increase of 29293.3% in 2024 and a maximum decrease of 48739.54% in 2024.
  • Vertex Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 93.25 in 2023, then skyrocketed by 292.93% to 366.43 in 2024, then dropped by 0.27% to 365.42 in 2025.
  • Its Interest Coverage Ratio stands at 365.42 for Q4 2025, versus 359.45 for Q3 2025 and 311.11 for Q2 2025.